Hereditary Amyloidosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-09-06
Clinical Trial Update: APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis [Phase 3]
Phase 3 study of patisiran (ALN-TTR02) for transthyretin-mediated amyloidosis has completed with results posted in 2018.